Continually rising healthcare costs impede some patients from optimal treatment. One common barrier to effective treatment is the affordability of medications. Recently, Cost Plus Drugs (CPD) came to the pharmaceutical market to offer prescriptions at a 15% markup from manufacturer pricing and a flat $5 shipping cost.Our study aimed to see how this new company's most common surgery and genitourinary-specific drug prices compete with the current retail market and GoodRx, a nationally endorsed prescription discount program.
